Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 1 recruiting now early-phase tilt small index

Fatty Acids, Omega-3: early-phase trial registry

1 of 1 indexed Fatty Acids, Omega-3 trials are currently recruiting, with more weight in Phase 1-2.

Corpus placement: #11,370 of 28,707 conditions by registered trial count.

1 US clinical trials · 1 currently recruiting · #11,370 of 28,707 conditions by registered trial count

Fatty Acids, Omega-3: 1 US clinical trial tracked, 1 recruiting.

Fatty Acids, Omega-3 is the subject of 1 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is Michal Schnaider Beeri, Ph.D., running 1 of these trials.

Enrollment posture brief

Registry condition fatty-acids-omega-3

OPEN 1 | RECR 100% | LATE 0 | EARLY 1 | RANK #11370 | SPON 1

Nearest open-share peer: Aortic Arch Aneurysm (100% recruiting · 5 trials)

Fatty Acids, Omega-3 (this)100%Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%
Open-enrollment share among volume-matched conditions near Fatty Acids, Omega-3

Fatty Acids, Omega-3 lists 1 open slots (100% of 1 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Fatty Acids, Omega-3 on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Fatty Acids, Omega-3 is recruiting above its size-band peers.

    1 of 1 indexed trials (100%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Phase 21

Phase Distribution

PhaseTrial count
Phase 2 1

Top Sponsors

Named interventions

Most-linked intervention names on Fatty Acids, Omega-3 records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Placebo Control Group Dietary supplement
1 trials
Alpha-Linolenic Acid (2.6 g/day) Drug
1 trials

US sites by state

Facility locations filed on Fatty Acids, Omega-3 trials. A trial with sites in several states counts in each.

New Jersey 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Fatty Acids, Omega-3 page

1 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Fatty Acids, Omega-3 condition card totals 1 registered trials; most-linked intervention Placebo Control Group; top US site state New Jersey. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.